Uveal melanoma: in the era of new treatments

Uveal Melanoma (UM), also called choroidal melanoma, is a rare and poorly described disease that occurred in 3490 new cases in the United States in 2023 [1 –2]. It is the most common primary intraocular malignancy in adults. Although 5-year survival is relatively high at the localized and regional stages, 85% and 67% respectively, the challenge of managing this disease lies primarily in the metastatic stage where survival rates drop to only 16% [3]. The incidence of UM has been constant since the last few years.

Source: Cancer Treatment Reviews - July 7, 2023 Category: Cancer & Oncology Authors: M. Wespiser, E. Neidhardt, S. Negrier Tags: Anti-tumour Treatment Source Type: research